A 38-year-old woman with a history of porphyria cutanea tarda is scheduled for elective abdominal hysterectomy. The anesthesiologist plans to use propofol for induction and maintenance anesthesia. However, the surgical team requests that volatile anesthesia be used for cost containment at this tertiary care center in rural India. The anesthesiologist must select an inhalational agent that is safe in porphyria. Which of the following volatile anesthetics is the SAFEST choice for this patient?

Explanation

## Inhalational Anesthetics in Acute Intermittent Porphyria (AIP) and Porphyria Cutanea Tarda (PCT) **Key Point:** Sevoflurane is the safest volatile anesthetic in patients with porphyria. Isoflurane, desflurane, and halothane are either contraindicated or carry significant risk of precipitating acute porphyric crisis. **High-Yield:** Porphyrias are a group of metabolic disorders affecting heme biosynthesis. Acute intermittent porphyria (AIP) and variegate porphyria (VP) are the most dangerous forms; porphyria cutanea tarda (PCT) is generally non-acute but can be triggered by certain drugs. Many anesthetic agents induce cytochrome P450 enzymes, particularly CYP3A4 and CYP2C9, which upregulate the rate-limiting enzyme ALA synthase, depleting heme pools and precipitating acute porphyric crisis. ### Pathophysiology of Porphyria-Induced Anesthetic Crisis 1. **Heme depletion:** Certain drugs induce CYP450 enzymes, increasing heme consumption 2. **Upregulation of ALA synthase:** Negative feedback loss → overproduction of δ-aminolevulinic acid (ALA) and porphobilinogen (PBG) 3. **Neurovisceral manifestations:** Abdominal pain, autonomic instability, neuropsychiatric symptoms, seizures, respiratory paralysis 4. **Mortality:** Acute porphyric crisis carries 5–10% mortality if unrecognized ### Volatile Anesthetic Safety Profile in Porphyria | Agent | CYP450 Induction | Porphyria Risk | Clinical Use | | --- | --- | --- | --- | | **Sevoflurane** | Minimal | **SAFE** | Preferred volatile agent | | **Isoflurane** | Moderate | **CONTRAINDICATED** | Induces CYP3A4 and CYP2C9 | | **Desflurane** | Moderate–High | **CONTRAINDICATED** | Potent CYP450 inducer | | **Halothane** | Minimal induction | **CONTRAINDICATED** | Hepatotoxicity risk; unpredictable metabolism | **Clinical Pearl:** Sevoflurane undergoes minimal hepatic metabolism (~3–5%) via CYP2E1, and does NOT induce other CYP450 isoforms. This makes it the only volatile anesthetic safe for routine use in porphyria patients. Isoflurane and desflurane are potent inducers of CYP3A4 and CYP2C9, directly triggering heme depletion and acute crisis. ### Why Halothane Is Contraindicated Despite Minimal Induction Although halothane does not significantly induce CYP450 enzymes, it is still contraindicated in porphyria because: - Hepatic metabolism is unpredictable and can produce toxic metabolites - Risk of halothane hepatitis (immune-mediated liver injury) in susceptible individuals - Halothane is now obsolete in most developed countries and is not recommended for any high-risk patient ### Safe Anesthetic Approach in Porphyria ```mermaid flowchart TD A[Patient with Porphyria Scheduled for Surgery]:::outcome --> B{Acute Intermittent Porphyria or Variegate Porphyria?}:::decision B -->|Yes| C[AVOID ALL VOLATILE AGENTS]:::urgent C --> D[Use TIVA: Propofol + Remifentanil]:::action B -->|No: PCT or Asymptomatic Carrier| E[Volatile Anesthesia Acceptable]:::decision E --> F[ONLY Sevoflurane]:::action F --> G[Avoid: Isoflurane, Desflurane, Halothane]:::urgent D --> H[Avoid: Barbiturates, Sulfonamides, NSAIDs, Phenytoin]:::urgent F --> I[Monitor: Urine color, abdominal pain, autonomic signs]:::action I --> J[Post-op: Adequate hydration, glucose, heme arginate if crisis]:::action ``` **Mnemonic:** **SAFE in Porphyria** — **S**evoflurane, **A**void inducers (isoflurane, desflurane), **F**avour TIVA (propofol + opioid), **E**nsure glucose + fluids post-op. ### Drugs to AVOID in Porphyria - **Inducers of CYP450:** Isoflurane, desflurane, barbiturates (thiopental, methohexital), phenytoin, carbamazepine, rifampicin - **Direct triggers:** Sulfonamides, NSAIDs, estrogens, danazol, certain antibiotics (erythromycin, tetracyclines) - **Volatile agents:** Isoflurane, desflurane, halothane ### Safe Anesthetic Drugs in Porphyria - **Induction:** Propofol (SAFE), etomidate (SAFE) - **Maintenance:** Propofol TIVA (SAFE), sevoflurane (SAFE for PCT/asymptomatic carriers) - **Opioids:** Morphine, fentanyl, remifentanil (all SAFE) - **Neuromuscular blockers:** Atracurium, vecuronium (SAFE); avoid mivacurium - **Local anesthetics:** Lidocaine, bupivacaine (SAFE) **Warning:** Porphyria cutanea tarda (PCT) is generally non-acute and does not typically cause neurovisceral crisis, but it can be triggered by certain drugs. The safest approach is to treat all porphyria patients as high-risk and use sevoflurane (if volatile anesthesia is necessary) or TIVA (preferred). ### Clinical Presentation of Acute Porphyric Crisis - **Abdominal pain** (often severe, out of proportion to findings) - **Autonomic instability:** Tachycardia, hypertension, hyperthermia - **Neuropsychiatric:** Confusion, hallucinations, agitation, seizures - **Neuromuscular:** Weakness, paralysis (including respiratory muscles) - **Urine:** Dark red or port-wine color (due to porphobilinogen) ### Management of Acute Crisis 1. **Stop triggering agent immediately** 2. **Supportive care:** IV fluids (dextrose 10%, target glucose >250 mg/dL), electrolyte correction 3. **Heme arginate:** 3–4 mg/kg IV daily × 3–14 days (gold standard; inhibits ALA synthase) 4. **Symptomatic:** Anticonvulsants (gabapentin, magnesium sulfate), analgesics (opioids safe), beta-blockers for autonomic symptoms 5. **Avoid:** Phenytoin (inducer), benzodiazepines (generally safe but avoid long-acting agents) [cite:Gupta Ch 40 - Porphyrias and Anesthesia; Stoelting Ch 28]